To the Editor: Calin et al. (April 21, 2005, issue)1 proposedthat the truncating sequence change in ARLTS1, G446A (Trp149Stop),predisposes persons to a wide range of malignant conditionsincluding chronic lymphocytic leukemia (CLL). The assertionthat this variant predisposes persons to CLL was, however, basedon observations from only 17 familial patients of mixed ethnicbackground.
We conducted an association study to determine if this variantor five other coding single-nucleotide polymorphisms (cSNPs)in ARLTS1 predispose to CLL. We analyzed germ-line DNA from413 patients with CLL (259 men and 154 women; mean age, 58 years;range, 33 to . . . [Full Text of this Article]
This article has been cited by other articles:
Castellvi-Bel, S., Castells, A., de Cid, R., Munoz, J., Balaguer, F., Gonzalo, V., Ruiz-Ponte, C., Andreu, M., Llor, X., Jover, R., Bessa, X., Xicola, R. M., Pons, E., Alenda, C., Paya, A., Carracedo, A., Pique, J. M., for the Gastrointestinal Oncology Group of the Spa,
(2007). Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer. Carcinogenesis
28: 1687-1691
[Abstract][Full Text]
Petrocca, F., Iliopoulos, D., Qin, H. R., Nicoloso, M. S., Yendamuri, S., Wojcik, S. E., Shimizu, M., Di Leva, G., Vecchione, A., Trapasso, F., Godwin, A. K., Negrini, M., Calin, G. A., Croce, C. M.
(2006). Alterations of the Tumor Suppressor Gene ARLTS1 in Ovarian Cancer. Cancer Res.
66: 10287-10291
[Abstract][Full Text]